NFL BIOSCIENCES SA (ALNFL.PA) Stock Price, Forecast & Analysis
Europe - Euronext Paris - EPA:ALNFL - FR0014003XT0 - Common Stock
ALNFL.PA Key Statistics, Chart & Performance
The current stock price of ALNFL.PA is 1.6 EUR. In the past month the price increased by 35.59%. In the past year, price decreased by -12.85%.
ALNFL.PA Technical Analysis
ChartMill assigns a technical rating of 8 / 10 to ALNFL.PA. When comparing the yearly performance of all stocks, ALNFL.PA is one of the better performing stocks in the market, outperforming 77.41% of all stocks.
ALNFL.PA Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to ALNFL.PA. While ALNFL.PA seems to be doing ok healthwise, there are quite some concerns on its profitability.
ALNFL.PA Financial Highlights
Over the last trailing twelve months ALNFL.PA reported a non-GAAP Earnings per Share(EPS) of -0.36. The EPS increased by 54.35% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -50.64% | ||
| ROE | -84.25% | ||
| Debt/Equity | 0.01 |
ALNFL.PA Forecast & Estimates
11 analysts have analysed ALNFL.PA and the average price target is 2.99 EUR. This implies a price increase of 87% is expected in the next year compared to the current price of 1.6.
ALNFL.PA Ownership
About ALNFL.PA
Company Profile
NFL Biosciences SAS is a biotechnology company, which engages in the development of botanical drug candidates for the treatment of tobacco addiction and neurological diseases. The company is headquartered in Castelnau-Le-Lez, Occitanie and currently employs 4 full-time employees. The company went IPO on 2021-07-05. The firm's products help cure addictions through an approach based on botanical pharmaceutical agents. The company develops NFL-101, a patented, botanical drug candidate that aims at increasing the odds of quitting for smokers willing to quit. The firm applies scientific approach to other drug candidate with an initial focus targeting the growing addiction to cannabis.
Company Info
NFL BIOSCIENCES SA
199 rue Helene Boucher
Castelnau-le-Lez OCCITANIE FR
Employees: 4
Phone: 33411937667
NFL BIOSCIENCES SA / ALNFL.PA FAQ
Can you describe the business of NFL BIOSCIENCES SA?
NFL Biosciences SAS is a biotechnology company, which engages in the development of botanical drug candidates for the treatment of tobacco addiction and neurological diseases. The company is headquartered in Castelnau-Le-Lez, Occitanie and currently employs 4 full-time employees. The company went IPO on 2021-07-05. The firm's products help cure addictions through an approach based on botanical pharmaceutical agents. The company develops NFL-101, a patented, botanical drug candidate that aims at increasing the odds of quitting for smokers willing to quit. The firm applies scientific approach to other drug candidate with an initial focus targeting the growing addiction to cannabis.
What is the stock price of NFL BIOSCIENCES SA today?
The current stock price of ALNFL.PA is 1.6 EUR. The price decreased by -2.91% in the last trading session.
Does ALNFL stock pay dividends?
ALNFL.PA does not pay a dividend.
What is the ChartMill rating of NFL BIOSCIENCES SA stock?
ALNFL.PA has a ChartMill Technical rating of 8 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
Can you provide the number of employees for NFL BIOSCIENCES SA?
NFL BIOSCIENCES SA (ALNFL.PA) currently has 4 employees.
Can you provide the market cap for NFL BIOSCIENCES SA?
NFL BIOSCIENCES SA (ALNFL.PA) has a market capitalization of 20.27M EUR. This makes ALNFL.PA a Nano Cap stock.
Can you provide the ownership details for ALNFL stock?
You can find the ownership structure of NFL BIOSCIENCES SA (ALNFL.PA) on the Ownership tab.